Parkworth Wealth Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$86 Sell
3
-2
-40% -$60 ﹤0.01% 1169
2025
Q1
$165 Buy
5
+3
+150% +$98 ﹤0.01% 779
2024
Q4
$58 Buy
+2
New +$57 ﹤0.01% 1125

Other funds holding ALKS

Parkworth Wealth Management's ALKS Position: Q2 2025 in Review

Parkworth Wealth Management reduced its Alkermes (ALKS) stake by 40% in Q2 2025, selling an estimated $60 and leaving 3 shares worth $86. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

Parkworth Wealth Management first reported a position in ALKS in Q4 2024 and has held it in 3 quarters since. The position peaked at $165 in Q1 2025. 353 funds tracked by Wall St. Rank hold ALKS as of Q2 2025.

  • Parkworth Wealth Management held 3 shares of Alkermes worth $86 as of Q2 2025.
  • Parkworth Wealth Management sold 2 Alkermes shares in Q2 2025, an estimated $60.
  • Alkermes made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #1169 holding.
  • Parkworth Wealth Management first reported a position in Alkermes in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's Alkermes position peaked at $165 in Q1 2025.
  • 353 funds tracked by Wall St. Rank held Alkermes as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.